For decades, the scientific theory of depression focused on chemicals — serotonin, norepinephrine and dopamine. Nearly every ...

NRx has received a positive review letter (Discipline Review Letter) addressing Drug Quality requesting only “Minor” administrative changesNRx ...

Treatment-resistant depression affects millions of Americans who have tried multiple antidepressants without finding relief. After cycling through different medications, therapy approaches, and ...

When Jason Prinzo was diagnosed with depression, he was five years old. His father was an alcoholic and a drug addict who was ...

Roughly one in ten Americans suffers from major depressive disorder (MDD) at any given time. In total, up to 20 percent of people will deal with its symptoms at some point in their lives. Despite its ...

A Cleveland Clinic psychiatrist explains how ketamine therapy is transforming depression treatment—and why it works when ...

Off-label ketamine is being increasingly used in clinical practice for treatment-resistant depression. Serial infusions of ketamine were no better than midazolam infusions for hospitalized patients ...

Add Yahoo as a preferred source to see more of our stories on Google. From operating rooms to dance floors, Ketamine's popularity is soaring. But what makes it so appealing - and why is it riskier ...

Less-common depression treatments, including transcranial magnetic stimulation, ketamine, and esketamine, can boost the effectiveness of antidepressant medications.

Ketamine is increasingly being used as an off-label treatment for depression, but researchers have found it might not provide any long term benefits. Depression has been recognised by the World Health ...

According to the Centers for Disease Control and Prevention, nearly 13 million individuals seriously consider suicide annually, and around 1.5 million attempt suicide. Preliminary data for 2024 ...

June 7, 2012 (Phoenix, Arizona) — The administration of 6 low-dose intravenous infusions of the fast-acting drug ketamine over 2 weeks shows efficacy in improving symptoms in patients with ...